Endo Announces Successful Culmination of Litigation Regarding FDA Compounding Policy

DUBLIN, Sept. 30, 2019 -- (Healthcare Sales & Marketing Network)-- Endo International plc ("Endo") (NASDAQ: ENDP) today announced the successful culmination of two litigation matters before the U.S. District Court for the District of Columbia r...Biopharmaceuticals, Generics, Litigation
Endo International, compounding, vasopressin, Vasostrict